Close Menu

CHICAGO (GenomeWeb) – Startup firm LunaDNA, a blockchain-based genomic and medical research company, said late Monday that it has landed $2 million in seed funding.

Several former Illumina executives were among the group of individual investors, including ex-Illumina Chief Information Officer Scott Kahn, Illumina Cofounder David Walt, and Gavin Saitowitz, CEO and cofounder of Prelude Capital. San Diego-based Luna simultaneously announced that Kahn has been named CIO of the startup.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.